Market Insights

The blame game could still happen to you, but if you're aware of your clients' unique situations, it might not.

Direxion, a $13.6 billion money manager, is starting an ETF. Here's what you need to know.

Generic drugs account for more than 90 percent of U.S. prescriptions. Overcapacity and the emergence of big purchasing groups have slammed manufacturers' margins.

Voluntary benefits are becoming more entrenched as part of a company's core employee benefit strategy.

From baby boomers to Generation Z, today's employers need to offer a range of voluntary benefits that appeal to many different types of employees.

A deal or joint venture between Humana and Walmart might help defend against competitive threats in both the retail and health care industries.

Markets have been roiled by worries over talk of a potential trade war and a sell-off in tech stocks.

A combination of artificial and human intelligence data analytics, offering the opportunity to bring greater customization to medical approaches, is expected to increase in demand over the next few years.